Valuation

GILDGILEAD

StockNasdaqAmerika Birleşik DevletleriHealth careEU retail: available

4/10

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
Metric	GILD	Sector median	vs median
P/E	—	28,8 · n=114	—
P/B	16,1	3,0 · n=196	%434 above
P/S	6,3	3,7 · n=202	%68 above
EV/EBIT	—	24,1 · n=103	—
Free-cash-flow yield	%6,8	%2,8 · n=187	%143 above
Dividend yield	%2,12	%0,00 · n=215	—
Return on equity	−%20,6	%2,7 · n=193	%874 below
Return on invested capital	−%6,7	%3,5 · n=176	%289 below
Gross margin	%79,6	%62,5 · n=152	%27 above
Net debt / EBITDA	—	1,19 · n=108	—

Value factor: 46 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

Instrument	P/E	P/B	EV/EBIT	Free-cash-flow yield	Dividend yield	Smart Score
LLYEli Lilly & Co	42,6	33,6	—	%1,6	%0,6	6/10
JNJJohnson & Johnson	29,1	7,2	—	%3,6	%2,1	8/10
ABBVAbbVie	79,9	—	33,5	%3,6	%3,0	5/10
MRKMerck	114,6	8,7	—	%4,4	%2,3	8/10
UNHUnitedHealth	25,1	3,4	18,6	%6,7	%2,3	9/10
TMOThermo Fisher Scientific	35,7	4,7	35,2	%2,9	%0,3	8/10
AMGNAmgen	26,3	19,7	24,0	%4,4	%2,3	6/10
ABTAbbott	28,5	3,4	26,8	%4,1	%3,0	5/10
PFEPfizer	38,4	2,0	—	%6,6	%5,9	1/10
DHRDanaher	39,4	3,0	35,1	%3,5	%0,7	5/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Haz 2026 · filed 06 Ağu 2026

Buradan sözleşmeden çıkın · AB tüketicileri: Bir satın alma işlemini iptal etmek için 14 gün.